| Literature DB >> 29472885 |
Jordi Manuello1,2, Andrea Nani1,2,3, Enrico Premi4, Barbara Borroni4, Tommaso Costa1,2, Karina Tatu1,2, Donato Liloia2, Sergio Duca1, Franco Cauda1,2.
Abstract
Gray matter alterations are typical features of brain disorders. However, they do not impact on the brain randomly. Indeed, it has been suggested that neuropathological processes can selectively affect certain assemblies of neurons, which typically are at the center of crucial functional networks. Because of their topological centrality, these areas form a core set that is more likely to be affected by neuropathological processes. In order to identify and study the pattern formed by brain alterations in patients' with Alzheimer's disease (AD), we devised an innovative meta-analytic method for analyzing voxel-based morphometry data. This methodology enabled us to discover that in AD gray matter alterations do not occur randomly across the brain but, on the contrary, follow identifiable patterns of distribution. This alteration pattern exhibits a network-like structure composed of coaltered areas that can be defined as coatrophy network. Within the coatrophy network of AD, we were able to further identify a core subnetwork of coaltered areas that includes the left hippocampus, left and right amygdalae, right parahippocampal gyrus, and right temporal inferior gyrus. In virtue of their network centrality, these brain areas can be thought of as pathoconnectivity hubs.Entities:
Keywords: Alzheimer’s disease; brain alterations; coatrophy network; gray matter atrophy; pathoconnectivity hubs; tauopathy; voxel-based morphometry
Year: 2018 PMID: 29472885 PMCID: PMC5810291 DOI: 10.3389/fneur.2017.00739
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Selected studies for the meta-analysis.
| ID | Reference | Journal | AD patients | Age | Scanner field (T) | Slice thick (mm) | Smoothing (mm) | Software | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Total | Min | Max | Mean ± SD | |||||||
| 1 | Agosta et al. ( | Radiology | 14 | 9 | 23 | – | – | 74.6 ± 8.6 | 1.5 | 0.9 × 0.5 × 0.5 | 8 | SPM5 |
| 2 | Baron et al. ( | NeuroImage | 8 | 11 | 19 | 63 | 85 | 73 ± 5 | 1.5 | 1.5 × 1 × 1 | 12 | SPM2 |
| 3 | Baxter et al. ( | Journal of Alzheimer’s Disease | 11 | 4 | 15 | 64 | 91 | 75.5 ± 7.8 | 1.5 | 1.5 × 0.9 × 0.9 | 12 | SPM2 |
| 4 | Berlingeri et al. ( | Behavioral Neuroscience | 8 | 13 | 21 | – | – | 76.5 | 1.5 | 1 × 1 × 1 | – | SPM2 |
| 5 | Boxer et al. (69) | Archives of Neurology | 8 | 3 | 11 | – | – | 69.6 ± 8.2 | 1.5 | – | 12 | SPM99 |
| 6 | Bozzali et al. ( | Neurology | 11 | 11 | 22 | – | – | 67.9 ± 7.6 | 1.5 | 1 | 12 | SPM2 |
| 7 | Brenneis et al. ( | NeuroReport | 3 | 7 | 10 | – | – | 73.1 ± 7.6 | 1.5 | 1 × 1 × 1 | – | SPM99 |
| 8 | Canu et al. ( | Neurobiology of Aging | 13 | 29 | 42 | – | – | 77.8 ± 4.8 | 1 | 1.3 | 8 | SPM8 |
| 62.5 ± 4.5 | ||||||||||||
| 9 | Chetelat et al. ( | NeuroReport | 7 | 9 | 16 | 63 | 85 | 72.1 ± 5.8 | 1.5 | 2 × 2 × 2 | 12 | SPM99 |
| 10 | Farrow et al. ( | Psychiatry Research NeuroImaging | – | – | 14 | 68 | 87 | 77 ± 7 | 1.5 | 1 × 1 × 1 | 8 | SPM2 |
| 78 ± 7 | ||||||||||||
| 11 | Feldmann et al. ( | Psychiatry Research | 4 | 2 | 6 | – | – | 61.1 ± 7.7 | 1 | 0.8 | 8 | SPM2 |
| 12 | Frisoni et al. ( | Journal of Neurology, Neurosurgery, and Psychiatry | 6 | 23 | 29 | 53 | 86 | 74 ± 9 | 1.5 | 1.3 | 8 | SPM99 |
| 13 | Guo et al. ( | Neuroscience Letters | 6 | 7 | 13 | 58 | 81 | 72.1 ± 6.5 | 3 | 0.5 × 0.5 × 1 | 8 | SPM2 |
| 14 | Hall et al. ( | Alzheimers Dementia | 16 | 31 | 47 | – | – | 83.2 ± 5 | 1.5 | 1 × 1 × 1 | 10 | SPM2 |
| 79.4 | ||||||||||||
| 15 | Hamalainen et al. ( | Neurobiology of Aging | 5 | 10 | 15 | 62 | 83 | 73.1 ± 6.7 | 1.5 | 2 × 2 × 2 | – | SPM2 |
| 16 | Hirao et al. ( | Nuclear Medicine Communications | 32 | 29 | 61 | 48 | 87 | 70.6 ± 8.4 | 1.5 | 1.23 | 12 | SPM2 |
| 17 | Honea et al. ( | Alzheimer’s Disease and Related Disorders | 23 | 37 | 60 | – | – | 74.3 ± 6.3 | 3 | 1 × 1 × 1 | 10 | SPM5 |
| 18 | Ishii et al. ( | European Journal of Nuclear Medicine and Molecular Imaging | 8 | 22 | 30 | – | – | 66.8 ± 7.0 | 1.5 | 1.5 | 12 | SPM99 |
| 19 | Kanda et al. ( | European Journal of Nuclear Medicine and Molecular Imaging | – | – | 20 | – | – | 65 | 1.5 | 1.5 | – | SPM2 |
| 20 | Kawachi et al. ( | European Journal of Nuclear Medicine and Molecular Imaging | 9 | 23 | 32 | – | – | 67 ± 4.5 | 1.5 | – | 12 | SPM99 |
| 21 | Kim et al. ( | Journal of Clinical Neuroscience | – | – | 61 | – | – | 70.1 ± 5.0 | 3 | 1 | 12 | SPM2 |
| 71.1 ± 6.1 | ||||||||||||
| 73.9 ± 5.5 | ||||||||||||
| 22 | Matsuda et al. ( | Journal of Nuclear Medicine | 11 | 4 | 15 | 59 | 81 | 71.1 ± 7.1 | 1 | 1.23 | 12 | SPM99 |
| 23 | Matsunari et al. ( | Journal of Nuclear Medicine | 12 | 15 | 27 | – | – | 68.6 ± 6.8 | 1.5 | 0.78 × 1.04 × 1.4 | 12 | SPM2 |
| 24 | Mazere et al. ( | NeuroImage | 3 | 5 | 8 | – | – | 80 ± 6.8 | 1.5 | 1 | 8 | SPM2 |
| 25 | Miettinen et al. ( | European Journal of Neuroscience | 5 | 11 | 16 | 63 | 83 | 74.8 ± 5.4 | 1.5 | 2 × 2 × 2 | 12 | SPM2 |
| 26 | Ohnishi et al. ( | American Journal of Neuroradiology | 11 | 15 | 26 | 59 | 79 | 72.1 ± 1.1 | 1.5 | – | 12 | – |
| 27 | Rabinovici et al. ( | American Journal of Alzheimer’s Disease and Other Dementias | 5 | 6 | 11 | – | – | 64.5 ± 9.7 | 1.5 | – | 12 | SPM2 |
| 28 | Rami et al. ( | International Journal of Geriatric Psychiatry | 9 | 22 | 31 | – | – | 76.4 ± 6.8 | 1.5 | 1.5 | 10 | SPM2 |
| 29 | Remy et al. ( | NeuroImage | 1 | 7 | 8 | – | – | 72.2 ± 10.8 | 1.5 | 1 × 1 × 1 | 8 | SPM2 |
| 30 | Shiino et al. ( | NeuroImage | 19 | 21 | 40 | 55 | 82 | 71.1 + 9.7 | 1.5 | – | 12 | SPM99 |
| 31 | Takahashi et al. ( | American Journal of Neuroradiology | 20 | 31 | 51 | – | – | 72.6 ± 2.9 | 1.5 | 1.5 | 6 | SPM8 |
| 32 | Testa et al. ( | Journal of Magnetic Resonance Imaging | 2 | 5 | 7 | – | – | 73 ± 11 | 1.5 | 2 × 2 × 2 | 8 | SPM99 |
| 33 | Waragai et al. ( | Journal of the Neurological Sciences | 7 | 8 | 15 | – | – | 71 ± 5.1 | 1.5 | 2 | 12 | SPM5 |
| 34 | Whitwell et al. ( | Neurobiology of Aging | 16 | 22 | 38 | – | – | 65.3 ± 6.9 | 1.5 | 1.6 | 8 | SPM2 |
| 35 | Xie et al. ( | Neurology | 8 | 5 | 13 | 62 | 82 | 71.7 | 1.5 | 1.6 | 8 | SPM2 |
| 36 | Zahn et al. ( | Psychiatry Research NeuroImaging | 4 | 6 | 10 | – | – | 66.5 ± 8.9 | 1.5 | 1.5 × 1.5 × 1.5 | 8 | SPM2 |
Where no information about slice thickness was provided, the voxel-size was expressed. The items are the result of the entire selection process as shown in PRISMA (Figure S1 in Supplementary Material) flow chart.
Marginal probabilities between altered and unaltered nodes.
| Node | ||||
|---|---|---|---|---|
| Node b | Altered | Unaltered | ||
| θ1 | θ3 | θ1 + θ3 | ||
| θ2 | θ4 | θ2 + θ4 | ||
| θ1 + θ2 | θ3 + θ4 | 1 | ||
Figure 1Gray matter anatomical likelihood estimation (ALE) results. The image summarizes the results of all the experiments considered in this meta-analysis. Colors from red to green show gray matter decreases [ALE maps were thresholded using voxel-level FWD p < 0.05 (104) and visualized using Brainvoyager QX].
Figure 2The left panels shows the nodes that entered the coatrophy calculation. The right panel shows the coatrophy matrix. Colors from blue to red indicate increasing Patel’s k values (i.e., increasing coalteration probabilities).
Figure 3Morphometric coatrophy network results. Colors from blue to red indicate increasing Patel’s k values (i.e., increasing coalteration probabilities).
Figure 4Topological analysis of the coatrophy network of Alzheimer’s disease (organic yFiles Layout). Colors and dimensions of nodes indicate their topological degree (smaller node = lower degree; from green to red = from lower to higher values). Thickness of edges indicate the degree of edge betweenness (smaller edge = lower degree).
Figure 5Topological analysis of the coatrophy network of Alzheimer’s disease. Nodes referring to the same brain areas or strictly close one to the other have been collapsed in a single node.
Figure 6Anatomical localization of the nodes in the hippocampi. Coordinates refers to Talairach space (right sagittal slice x = 25, left x = 30). Nodes are numerically labeled according to a rostrocaudal criterion.
Figure 7Detailed illustration of the role of the hippocampi in the coatrophy network of Alzheimer’s disease. Green edges are intrahemispheric, while red edges are interhemispheric.
Figure 8Network clustering with k-core decomposition algorithm. Colors and dimensions of nodes indicate their topological degree (smaller node = lower degree; from green to red = from lower to higher values). Thickness of edges indicate the degree of edge betweenness (smaller edge = lower degree). Both node degree and edge betweenness values refer to the original coatrophy network.